ArticleJournal of the American Heart Association2026
Interferon-γ-Responsive Microglia-Derived Extracellular Vesicles Inhibited Neurogenesis After Stroke via MicroRNA-199a-5p/
Article in Journal of the American Heart Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have reported the presence of interferon-responsive microglia in the brain after central nervous system injury. However, their roles and the underlying mechanisms in neurological function recovery remain poorly understood.
methodsAdult male mice were subjected to 90-minute transient middle cerebral artery occlusion, and brain tissues were analyzed using single-cell RNA sequencing (scRNA-seq) at 14 days after stroke. Immunostaining, quantitative real-time polymerase chain reaction and ELISA were conducted to validate the presence of interferon-γ-responsive microglia in stroke mice brains. Extracellular vesicles (EVs) were isolated from interferon-γ-treated BV2 microglia via ultracentrifugation. Interferon-γ EVs were then used to treat neural stem cells (NSCs) in vitro or administered intravenously to mice every other day, starting at 7 days after transient middle cerebral artery occlusion. Neurobehavioral tests, cresyl violet staining, Golgi staining, and immunostaining were performed to evaluate NSC differentiation, neurogenesis, and neurobehavioral recovery. Micro RNA (miR) sequencing and bioinformatic analysis were conducted to explore targeted genes and signaling pathways underlying interferon-γ EV-mediated inhibition of neurogenesis.
resultsSingle-cell RNA sequencing, immunostaining, quantitative real-time polymerase chain reaction, and ELISA showed the presence of interferon-γ-responsive microglia in stroke mice brains. Interferon-γ EVs were internalized by NSCs, leading to reduced NSC survival and neuronal differentiation. Administration of interferon-γ EVs increased brain atrophy volume, inhibited neurobehavioral recovery and neurogenesis in mice after stroke. miRNA array revealed 12 upregulated microRNAs, and treatment with miR-199a-5p mimic inhibited the survival and neuronal differentiation of NSCs, and knockdown of miR-199a-5p in interferon-γ EVs increased neurogenesis in stroke mice. miRNA database analysis and luciferase reporter assay identified
conclusionsOur study demonstrated that interferon-γ EVs inhibited the survival and neuronal differentiation of NSCs, exacerbating brain injury via the miR-199a-5p/
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.